Validation of a clinical blood-based decision aid to guide immunotherapy treatment in patients with non-small cell lung cancer
{{output}}
Background: The widespread introduction of immunotherapy in patients with advanced non-small cell lung cancer (NSCLC) has led to durable responses but still many patients fail and are treated beyond progression. ... ...
